Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I/II Study of Vaccination Priming and Vaccine Boosting With Allogeneic Human GM-CSF Gene Transduced Irradiated Prostate Cancer Cell Vaccines in Patients With Prostate Cancer

NCT00140374 is registered in ClinicalTrials.gov with Cell Genesys as lead sponsor.

NCT NCT00140374
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00140374 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I/II Study of Vaccination Priming and Vaccine Boosting With Allogeneic Human GM-CSF Gene Transduced Irradiated Prostate Cancer Cell Vaccines in Patients With Prostate Cancer
Lead sponsor
Cell Genesys
Phase
Phase 1/2
Overall status
Completed
Start date
December 31, 1998
Completion date
February 28, 2001
Enrollment
36
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer